BDFS Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$532K Sell
1,020
-2
-0.2% -$1.1K 0.26% 65
2026
Q2
$538K Buy
1,022
+117
+13% +$65.6K 0.23% 76
2026
Q1
$509K Sell
905
-87
-9% -$55.8K 0.24% 79
2025
Q4
$671K Hold
992
– – 0.34% 49

Other funds holding IDXX

BDFS Capital's IDXX Position: Q3 2026 in Review

BDFS Capital reduced its Idexx Laboratories (IDXX) stake by 0.2% in Q3 2026, selling an estimated $1.1K and leaving 1,020 shares worth $532K. The position accounts for 0.26% of the portfolio, ranked #65.

BDFS Capital first reported a position in IDXX in Q4 2025 and has held it in 4 quarters since. The position peaked at $671K in Q4 2025. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • BDFS Capital held 1,020 shares of Idexx Laboratories worth $532K as of Q3 2026.
  • BDFS Capital sold 2 Idexx Laboratories shares in Q3 2026, an estimated $1.1K.
  • Idexx Laboratories made up 0.26% of BDFS Capital's portfolio in Q3 2026, its #65 holding.
  • BDFS Capital first reported a position in Idexx Laboratories in Q4 2025 and has held it in 4 quarters since.
  • BDFS Capital's Idexx Laboratories position peaked at $671K in Q4 2025.
  • 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on BDFS Capital's 13F filing for Q3 2026, filed 14 Oct 2026.